Molecular insights into fosfomycin resistance in Escherichia coli
- PMID: 28093485
- DOI: 10.1093/jac/dkw573
Molecular insights into fosfomycin resistance in Escherichia coli
Abstract
Objectives: Fosfomycin activity in Escherichia coli depends on several genes of unknown importance for fosfomycin resistance. The objective was to characterize the role of uhpT , glpT , cyaA and ptsI genes in fosfomycin resistance in E. coli.
Methods: WT E. coli BW25113 and null mutants, Δ uhpT , Δ glpT , Δ cyaA , Δ ptsI , Δ glpT-uhpT , Δ glpT-cyaA , Δ glpT-ptsI , Δ uhpT-cyaA , Δ uhpT-ptsI and Δ ptsI-cyaA , were studied. Susceptibility to fosfomycin was tested using CLSI guidelines. Fosfomycin mutant frequencies were determined at concentrations of 64 and 256 mg/L. Fosfomycin in vitro activity was tested using time-kill assays at concentrations of 64 and 307 mg/L (human C max ).
Results: Fosfomycin MICs were: WT E. coli BW25113 (2 mg/L), Δ glpT (2 mg/L), Δ uhpT (64 mg/L), Δ cyaA (8 mg/L), Δ ptsI (2 mg/L), Δ glpT-uhpT (256 mg/L), Δ glpT-cyaA (8 mg/L), Δ glpT-ptsI (2 mg/L), Δ uhpT-cyaA (512 mg/L), Δ uhpT-ptsI (64 mg/L) and Δ ptsI-cyaA (32 mg/L). In the mutant frequency assays, no mutants were recovered from BW25113. Mutants appeared in Δ glpT , Δ uhpT , Δ cyaA and Δ ptsI at 64 mg/L and in Δ uhpT and Δ cyaA at 256 mg/L. Δ glpT-ptsI , but not Δ glpT-cyaA , Δ uhpT-cyaA or Δ uhpT-ptsI , increased the mutant frequency compared with the highest frequency found in each single mutant. In time-kill assays, all mutants regrew at 64 mg/L. Initial bacterial reductions of 2-4 log 10 cfu/mL were observed for all strains, except for Δ uhpT-ptsI , Δ glpT-uhpT and Δ uhpT-cyaA . Only Δ glpT and Δ ptsI mutants were cleared using 307 mg/L.
Conclusions: Fosfomycin MIC may not be a good efficacy predictor, as highly resistant mutants may appear, depending on other pre-existing mutations with no impact on MIC.
© The Author 2017. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Similar articles
-
Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli.Int J Antimicrob Agents. 2010 Apr;35(4):333-7. doi: 10.1016/j.ijantimicag.2009.11.011. Epub 2010 Jan 13. Int J Antimicrob Agents. 2010. PMID: 20071153
-
CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.J Antimicrob Chemother. 2009 Oct;64(4):712-7. doi: 10.1093/jac/dkp288. Epub 2009 Aug 11. J Antimicrob Chemother. 2009. PMID: 19671590
-
The glycerol-3-phosphate permease GlpT is the only fosfomycin transporter in Pseudomonas aeruginosa.J Bacteriol. 2009 Nov;191(22):6968-74. doi: 10.1128/JB.00748-09. Epub 2009 Sep 4. J Bacteriol. 2009. PMID: 19734311 Free PMC article.
-
Elevated Expression of GlpT and UhpT via FNR Activation Contributes to Increased Fosfomycin Susceptibility in Escherichia coli under Anaerobic Conditions.Antimicrob Agents Chemother. 2015 Oct;59(10):6352-60. doi: 10.1128/AAC.01176-15. Epub 2015 Jul 27. Antimicrob Agents Chemother. 2015. PMID: 26248376 Free PMC article.
-
Zeocin resistance suppresses mutation in hypermutable Escherichia coli.Microbiology (Reading). 2003 Apr;149(Pt 4):815-816. doi: 10.1099/mic.0.C0111-0. Microbiology (Reading). 2003. PMID: 12686623 Review. No abstract available.
Cited by
-
Implications of two-component systems EnvZ/OmpR and BaeS/BaeR in in vitro temocillin resistance in Escherichia coli.J Antimicrob Chemother. 2024 Mar 1;79(3):641-647. doi: 10.1093/jac/dkae021. J Antimicrob Chemother. 2024. PMID: 38305703 Free PMC article.
-
An insight into genes responsible for fosfomycin resistance among uropathogens of asymptomatic bacteriuria during pregnancy: A North Indian study.Access Microbiol. 2023 Dec 11;5(12):000623.v5. doi: 10.1099/acmi.0.000623.v5. eCollection 2023. Access Microbiol. 2023. PMID: 38188241 Free PMC article.
-
Interplay among Different Fosfomycin Resistance Mechanisms in Klebsiella pneumoniae.Antimicrob Agents Chemother. 2021 Feb 17;65(3):e01911-20. doi: 10.1128/AAC.01911-20. Print 2021 Feb 17. Antimicrob Agents Chemother. 2021. PMID: 33361305 Free PMC article.
-
Activity of fosfomycin and amikacin against fosfomycin-heteroresistant Escherichia coli strains in a hollow-fiber infection model.Antimicrob Agents Chemother. 2023 May 1;65(5):e02213-20. doi: 10.1128/AAC.02213-20. Epub 2021 Mar 8. Antimicrob Agents Chemother. 2023. PMID: 33685903 Free PMC article.
-
In-patient evolution of a high-persister Escherichia coli strain with reduced in vivo antibiotic susceptibility.Proc Natl Acad Sci U S A. 2024 Jan 16;121(3):e2314514121. doi: 10.1073/pnas.2314514121. Epub 2024 Jan 8. Proc Natl Acad Sci U S A. 2024. PMID: 38190524 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical